Request Trial
shutterstock_1770737918_rafapress
rafapress / Shutterstock.com
4 May 2021MedTechAlex Baldwin

Fed Circ. agrees Bio-Rad infringed 10x patents

The US Court of Appeals for the Federal Circuit has affirmed a US International Trade Commission (ITC) decision that ruled Bio-Rad Laboratories had infringed three 10x Genomics patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss
20 October 2026   A panel rejected the Omnipod maker’s request for a rehearing in its trade secrets dispute with South Korean insulin pump maker EOFlow, leaving in place a ruling that overturned a $59.4 million damages award and raising questions over the three-year statute of limitations under the DTSA.
MedTech
Align Technology notches another win in escalating clear aligner feud
19 October 2026   The US clear aligner giant has dealt another blow to a Chinese rival, securing an infringement ruling at the UPC as the pair wage a growing patent dispute across Europe, the US and China.
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026   The two major medical device makers are clashing over Atraverse’s Hotwire system, with Boston Scientific claiming the product infringes its patented radiofrequency transseptal-access technology, used in heart surgery.


Editor's picks

WATCH: Medmix global IP head on building business-focused IP teams
In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026

Editor's picks

In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026

More features

10x and Parse set to end sequencing feud after appeals court defeat
Dr Reddy’s eyes appeal stakes as Boehringer hearing ends
Amarin and Hikma call time on six-year skinny label fight
WATCH: Medmix global IP head on building business-focused IP teams
Fish & Richardson hires duo with ‘sophisticated’ tech patent expertise
Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss
Boehringer accuses Dr Reddy’s of ‘weaponising’ plausibility
Align Technology notches another win in escalating clear aligner feud